FIELD: medicine; psychiatry.
SUBSTANCE: method of efficiency forecast for residual schizophrenia treatment by atypical neuroleptic quetiapine involves defining spectre of molecules with medium mass in blood serum before beginning of treatment. Low quantity of medium mass molecule fraction registered at wavelength of 230 nm, E230 fraction extinction rate under 0.12 units, and nuclear peptide index below 0.4 indicate low clinical efficiency of atypical neuroleptic quetiapine in residual schizophrenia treatment.
EFFECT: enhanced accuracy of efficiency forecast for residual schizophrenia treatment by atypical neuroleptic quetiapine before beginning of treatment.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF BORDER PSYCHIC DISORDERS | 2011 |
|
RU2455646C1 |
| PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
| METHOD FOR PREDICTION OF EPILEPSY SEVERITY | 2012 |
|
RU2499262C1 |
| METHOD OF TREATING PATIENTS WITH SCHIZOPRENIA | 2009 |
|
RU2415666C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF VISCERAL OBESITY IN PATIENTS WITH SCHIZOPHRENIA RECEIVING QUETIAPINE THERAPY | 2017 |
|
RU2659638C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
